5/29/2014 9:24:44 AM
NORCROSS, Ga., May 29, 2014 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (Nasdaq:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that the Company will present at the Jefferies 2014 Global Healthcare Conference, to be held June 2-5, 2014, in New York, NY. Dr. Harold H. Shlevin, Chief Operating Officer and Corporate Secretary of Galectin Therapeutics, will provide an overview of the Company's business and recent and upcoming milestones during his live presentation.
Help employers find you! Check out all the jobs and post your resume.
comments powered by